These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


348 related items for PubMed ID: 12499816

  • 1. [HBV DNA levels, aminotransferase and histological activity in young male patients with HBeAg positive chronic hepatitis B].
    Cho SC, Lee SH, Shinn JJ, Han SH, Roh BJ, Sohn JH, Lee DH, Kee CS.
    Taehan Kan Hakhoe Chi; 2002 Mar; 8(1):44-51. PubMed ID: 12499816
    [Abstract] [Full Text] [Related]

  • 2. [The prevalence and clinical significance of precore and core promoter mutations in Korean patients with chronic hepatitis B virus infection].
    Kim HJ, Yoo BC.
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):149-56. PubMed ID: 12499800
    [Abstract] [Full Text] [Related]

  • 3. HBV DNA level and antigen concentration in evaluating liver damage of patients with chronic hepatitis B.
    Xie Y, Zhao H, Dai WS, Xu DZ.
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):418-22. PubMed ID: 14599951
    [Abstract] [Full Text] [Related]

  • 4. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT.
    Kumar M, Sarin SK, Hissar S, Pande C, Sakhuja P, Sharma BC, Chauhan R, Bose S.
    Gastroenterology; 2008 May; 134(5):1376-84. PubMed ID: 18471514
    [Abstract] [Full Text] [Related]

  • 5. Significance of HBV DNA levels in liver histology of HBeAg and Anti-HBe positive patients with chronic hepatitis B.
    Yuen MF, Ng IO, Fan ST, Yuan HJ, Wong DK, Yuen JC, Sum SS, Chan AO, Lai CL.
    Am J Gastroenterol; 2004 Oct; 99(10):2032-7. PubMed ID: 15447768
    [Abstract] [Full Text] [Related]

  • 6. [Relationships between liver function test, serum HBeAg or HBV DNA level and liver pathological changes in patients with chronic hepatitis B].
    Xu QH, Shu X, Chen LB, Huang HH, Zhang K, Li G.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):422-4. PubMed ID: 19544633
    [Abstract] [Full Text] [Related]

  • 7. [Relationship among pathological changes in Liver tissues and level of serum HBV DNA, HBeAg and ALT of 194 patients with chronic hepatitis B].
    Zhao DY, Qin YQ, Tang XM, Liu GZ, Zheng W, Nong HR, Song JJ, Xie QY.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):35-7. PubMed ID: 17429530
    [Abstract] [Full Text] [Related]

  • 8. [Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
    Ying RS, Yang Z, Chen YY, Yang KL, Xiao YH, Wu LJ, Fan HM.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):585-8. PubMed ID: 23207151
    [Abstract] [Full Text] [Related]

  • 9. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].
    Kim KH, Na IH, Cha JM, Cho YK, Park SY, Kim HP, Song CS, Heo J, Cho M.
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):284-92. PubMed ID: 14695695
    [Abstract] [Full Text] [Related]

  • 10. e-antigen-negative chronic hepatitis B in Bangladesh.
    Ahmad N, Alam S, Mustafa G, Adnan AB, Baig RH, Khan M.
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):379-82. PubMed ID: 18693173
    [Abstract] [Full Text] [Related]

  • 11. Comparative study of genotype B and C hepatitis B virus-induced chronic hepatitis in relation to the basic core promoter and precore mutations.
    Watanabe K, Takahashi T, Takahashi S, Okoshi S, Ichida T, Aoyagi Y.
    J Gastroenterol Hepatol; 2005 Mar; 20(3):441-9. PubMed ID: 15740490
    [Abstract] [Full Text] [Related]

  • 12. Markers of disease activity in chronic hepatitis B virus infection.
    Yalcin K, Degertekin H, Yildiz F, Celik Y.
    Clin Invest Med; 2003 Feb; 26(1):27-34. PubMed ID: 12659467
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH, Lee CM, Hung CH, Hu TH, Wang JH, Wang JC, Lu SN, Changchien CS.
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [Abstract] [Full Text] [Related]

  • 14. [Relationship between liver pathological characteristics and serum HBeAg and HBV DNA in 1057 patients with chronic hepatitis B].
    Fan HM, Zhang CL, Ying RS, Chen ZM, Feng QC.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):130-2. PubMed ID: 18574537
    [Abstract] [Full Text] [Related]

  • 15. [Hepatopathy and hepatitis B virus infection in dialysis patients: cross-sectional study].
    Fabrizi F, Bisegna S, Mangano S, Alongi G, Colucci P, Finazzi S, De Vecchi AF, Ponticelli C.
    G Ital Nefrol; 2002 Apr; 19(2):149-54. PubMed ID: 12195413
    [Abstract] [Full Text] [Related]

  • 16. [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].
    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.
    Mikrobiyol Bul; 2007 Jan; 41(1):87-93. PubMed ID: 17427556
    [Abstract] [Full Text] [Related]

  • 17. Quantification of intrahepatic total hepatitis B virus DNA in chronic hepatitis B patients and its relationship with liver histology.
    Bayram A, Erkilic S, Ozkur A, Bayram M, Sari I.
    J Clin Pathol; 2008 Mar; 61(3):338-42. PubMed ID: 17693576
    [Abstract] [Full Text] [Related]

  • 18. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
    Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Chrysanthos N, Georgiou A, Kafiri G, Manolakopoulos S, Tiniakos DG, Giannousis I, Manesis EK, Archimandritis AJ.
    Gut; 2008 Apr; 57(4):500-6. PubMed ID: 18025069
    [Abstract] [Full Text] [Related]

  • 19. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
    Lu H, Ma LX, Xu WS, Zhang HY, Yu LJ, Duan HY.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):173-5. PubMed ID: 12681068
    [Abstract] [Full Text] [Related]

  • 20. The role of serial measurement of serum HBV DNA levels in patients with chronic HBeAg(-) hepatitis B infection: association with liver disease progression. A prospective cohort study.
    Zacharakis G, Koskinas J, Kotsiou S, Tzara F, Vafeiadis N, Papoutselis M, Maltezos E, Sivridis E, Papoutselis K.
    J Hepatol; 2008 Dec; 49(6):884-91. PubMed ID: 18674840
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.